Press releases

All press releases Regulatory

Regulatory press release 2022-01-13

FDA allows review of application for market approval for Xspray Pharma’s Dasynoc™

Regulatory press release 2021-11-30

Number of shares and votes in Xspray Pharma

Press release 2021-11-18

Xspray Pharma submits application for market approval to FDA for its product candidate Dasynoc

Press release 2021-11-15

Xspray Pharma strengthens the organization with IR and Communications function

Regulatory press release 2021-11-08

Xspray Pharma completes a directed new share issue to Flerie Invest, raising approximately SEK 100 million

Regulatory press release 2021-10-26

Xspray Pharma publishes interim report Q3, January – September 2021

Regulatory press release 2021-10-25

Xspray Pharma brings forward publication of the Q3 interim report

Regulatory press release 2021-10-15

Xspray Pharma’s Nomination Committee for the Annual General Meeting 2022

Regulatory press release 2021-10-13

Xspray Pharma has obtained results from bioequivalence studies with HyNap-Dasa ANDA and decides to focus on its improved dasatinib product, Dasynoc™

Press release 2021-08-30

All participants in Xspray Pharma studies have received their dose of generic version of dasatinib, HyNap-Dasa ANDA